Library / regulatory-reference
Vietnam: Drug Administration of Vietnam (DAV)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Drug Administration of Vietnam is the country's national medicines regulator, operating under the Ministry of Health, with responsibility for medicines, vaccines, biological products and traditional medicines. Medical devices are overseen by a companion department within the ministry.
Vietnam's pharmaceutical market is one of Southeast Asia's fastest growing, split between a large generic domestic sector and imported products, and the administration's registration policies shape that balance.
How products enter the market
Medicines require a marketing authorization following evaluation of quality, safety and efficacy, with requirements for stability data suited to the local climate and documentation that has been progressively aligned with international standards.
The administration operates reliance-informed mechanisms that give credit to approvals from stringent reference authorities for defined products, and it supervises domestic manufacturers and importers through licensing and inspection.
Regional and international role
The administration is an active participant in Southeast Asian harmonization work, and Vietnam's growing role as a vaccine and generic-medicine producer keeps it engaged with international quality benchmarks.
The country's expanding clinical-trials sector and its position in regional supply chains mean the administration's processes are followed closely by regional neighbors building their own capacity.
Using this profile
The administration publishes registers, guidance and announcements in Vietnamese through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: the Drug Administration of Vietnam illustrates the fast-growing-market regulator, balancing a domestic generic sector against import reliance while progressively aligning with international standards and regional harmonization.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.